🇺🇸 FDA
Company

IONIS

IONIS PHARMACEUTICALS INC

IONS pharma USA

Quick answer

IONIS is a pharma company (IONS) headquartered in CARLSBAD, CA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

Alicaforsen

Crohn's Disease

Phase 3 · small_molecule · completed

2 trials project

Donidalorsen

Hereditary Angioedema (HAE)

Phase 3 · small_molecule · active

1 trials project

Donidalorsen

Hereditary Angioedema

Phase 3 · small_molecule · active

4 trials project

Eplontersen

Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

Phase 3 · small_molecule · active

2 trials project

Eplontersen

Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

Phase 3 · small_molecule · active

1 trials project

ION363

Amyotrophic Lateral Sclerosis

Phase 3 · small_molecule · active

1 trials project

ION582

Angelman Syndrome

Phase 3 · small_molecule · active

2 trials project

ISIS 3521

Lung Cancer

Phase 3 · mab · completed

1 trials project

Inotersen

Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

Phase 3 · small_molecule · completed

1 trials project

Inotersen

FAP

Phase 3 · small_molecule · completed

2 trials project

Mipomersen

Hypercholesterolemia

Phase 3 · small_molecule · completed

1 trials project

Mipomersen sodium

Hypercholesterolemia

Phase 3 · small_molecule · completed

1 trials project

Olezarsen

Severe Hypertriglyceridemia

Phase 3 · small_molecule · active

3 trials project

Olezarsen

Familial Chylomicronemia Syndrome

Phase 3 · small_molecule · active

3 trials project

Olezarsen

Hypertriglyceridemia

Phase 3 · small_molecule · completed

2 trials project

Tofersen

ALS Caused by Superoxide Dismutase 1 (SOD1) Mutation

Phase 3 · small_molecule · completed

1 trials project

Tofersen

Amyotrophic Lateral Sclerosis

Phase 3 · small_molecule · completed

1 trials project

Volanesorsen

Hypertriglyceridemia

Phase 3 · small_molecule · completed

1 trials project

Volanesorsen

Familial Chylomicronemia Syndrome

Phase 3 · small_molecule · completed

2 trials project

mipomersen

Lipid Metabolism, Inborn Errors

Phase 3 · small_molecule · completed

2 trials project

mipomersen sodium

Heterozygous Familial Hypercholesterolemia

Phase 3 · small_molecule · completed

1 trials project

mipomersen sodium

Lipid Metabolism, Inborn Errors

Phase 3 · small_molecule · completed

2 trials project

volanesorsen

Familial Partial Lipodystrophy

Phase 3 · small_molecule · terminated

1 trials project

zilganersen

Alexander Disease

Phase 3 · small_molecule · active

1 trials

Drugs (2)

drug

donidalorsen sodium

DAWNZERA (AUTOINJECTOR)

 drug

olezarsen sodium

TRYNGOLZA (AUTOINJECTOR)

Patents (8)

patent

US 12409188

Modulators of HSD17B13 expression

Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12410430

Modulating apolipoprotein (A) expression

Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12410225

Modulation of dendritic cell lineages

Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12364753

CD8 binding agents

Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12350285

Compounds and methods for reducing ATXN3 expression

Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12351614

CLEC9A-based chimeric protein complexes

Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12351633

PD-1 and PD-L1 binding agents

Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12343357

Compositions and methods for modulating MECP2 expression

Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)